Miracor Medical raises 24M€
Funds will be used for clinical studies and initiation of commercialization
Miracor, Portfolio News
Miracor Medical granted FDA Breakthrough Device Designation for the PiCSO Impulse System
Miracor Medical SA (Miracor Medical) has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its PiCSO® Impulse System for treatment of STEMI patients.
Miracor Medical starts PiCSO-AMI-I randomized study in EU
Miracor Medical SA (Miracor Medical) today announced the initiation and first patient enrollment in the PICSO-AMI-I study to evaluate the benefits of PiCSO® therapy compared with conventional PCI for the treatment of anterior STEMI patients.
Miracor Medical raises € 25m
Funds will be used to support clinical and prepare commercial activities.
Company relocates from Austria to Belgium
Read more
